コンテンツへスキップ
Merck
  • Long-term sustained release of salicylic acid from cross-linked biodegradable polyester induces a reduced foreign body response in mice.

Long-term sustained release of salicylic acid from cross-linked biodegradable polyester induces a reduced foreign body response in mice.

Biomacromolecules (2015-01-07)
Yashoda Chandorkar, Nitu Bhaskar, Giridhar Madras, Bikramjit Basu
要旨

There has been a continuous surge toward developing new biopolymers that exhibit better in vivo biocompatibility properties in terms of demonstrating a reduced foreign body response (FBR). One approach to mitigate the undesired FBR is to develop an implant capable of releasing anti-inflammatory molecules in a sustained manner over a long time period. Implants causing inflammation are also more susceptible to infection. In this article, the in vivo biocompatibility of a novel, biodegradable salicylic acid releasing polyester (SAP) has been investigated by subcutaneous implantation in a mouse model. The tissue response to SAP was compared with that of a widely used biodegradable polymer, poly(lactic acid-co-glycolic acid) (PLGA), as a control over three time points: 2, 4, and 16 weeks postimplantation. A long-term in vitro study illustrates a continuous, linear (zero order) release of salicylic acid with a cumulative mass percent release rate of 7.34 × 10(-4) h(-1) over ∼1.5-17 months. On the basis of physicochemical analysis, surface erosion for SAP and bulk erosion for PLGA have been confirmed as their dominant degradation modes in vivo. On the basis of the histomorphometrical analysis of inflammatory cell densities and collagen distribution as well as quantification of proinflammatory cytokine levels (TNF-α and IL-1β), a reduced foreign body response toward SAP with respect to that generated by PLGA has been unambiguously established. The favorable in vivo tissue response to SAP, as manifest from the uniform and well-vascularized encapsulation around the implant, is consistent with the decrease in inflammatory cell density and increase in angiogenesis with time. The above observations, together with the demonstration of long-term and sustained release of salicylic acid, establish the potential use of SAP for applications in improved matrices for tissue engineering and chronic wound healing.

材料
製品番号
ブランド
製品内容

Sigma-Aldrich
ピリジン, ACS reagent, ≥99.0%
Sigma-Aldrich
ピリジン, suitable for HPLC, ≥99.9%
Sigma-Aldrich
ピリジン, anhydrous, 99.8%
Sigma-Aldrich
ピリジン, ReagentPlus®, ≥99%
Sigma-Aldrich
D-マンニトール, ≥98% (GC)
Sigma-Aldrich
無水酢酸, ReagentPlus®, ≥99%
Sigma-Aldrich
サリチル酸, ACS reagent, ≥99.0%
Sigma-Aldrich
Lactic acid, meets USP testing specifications
Sigma-Aldrich
グリコール酸, ReagentPlus®, 99%
Sigma-Aldrich
無水酢酸, puriss. p.a., ACS reagent, reag. ISO, reag. Ph. Eur., ≥99% (GC)
Supelco
マンニトール, Pharmaceutical Secondary Standard; Certified Reference Material
Sigma-Aldrich
無水酢酸, ACS reagent, ≥98.0%
Sigma-Aldrich
乳酸, 88%, FCC
Sigma-Aldrich
D-マンニトール, ACS reagent
Supelco
サリチル酸, Pharmaceutical Secondary Standard; Certified Reference Material
Sigma-Aldrich
D-マンニトール, ≥98% (GC), suitable for plant cell culture
Sigma-Aldrich
乳酸, natural, ≥85%
Sigma-Aldrich
ピリジン, puriss. p.a., ACS reagent, reag. Ph. Eur., ≥99.5% (GC)
Sigma-Aldrich
無水酢酸, 99.5%
Sigma-Aldrich
乳酸 溶液, ACS reagent, ≥85%
USP
マンニトール, United States Pharmacopeia (USP) Reference Standard
USP
サリチル酸, United States Pharmacopeia (USP) Reference Standard
Sigma-Aldrich
DL-乳酸, ~90% (T)
Supelco
乳酸, Pharmaceutical Secondary Standard; Certified Reference Material
Sigma-Aldrich
D-マンニトール, BioUltra, ≥99.0% (sum of enantiomers, HPLC)
Sigma-Aldrich
D-マンニトール, meets EP, FCC, USP testing specifications
Sigma-Aldrich
サリチル酸, BioXtra, ≥99.0%
Sigma-Aldrich
塩化セバコイル, 99%
Sigma-Aldrich
ピリジン, ≥99%
Sigma-Aldrich
サリチル酸, ≥99%, FG